In bladder cancer molecular subtyping, heat shock protein family A member 5 promotes tumor progression through dual mechanisms: regulating vascular endothelial growth factor A‐mediated angiogenesis and maintaining ferroptosis resistance via the p53/SLC7A11 pathway, highlighting its therapeutic potential [443, 444, 445]. Here, SLC7A11 is linked to neoplasm.